the use of antiretroviral drugs for the treatment and prevention of HIV infection.1 These guidelines recommended antiretroviral therapy for all HIV-positiv
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
ImportanceAntiretroviral therapy (ART) is the cornerstone of prevention and management of HIV infect...
ImportanceData on the use of antiretroviral drugs, including new drugs and formulations, for the tre...
This article gives a brief review of anti-retroviral agents with activity against the Human Immunode...
The article examines the efficacy and safety of HIV integrase inhibitors (raltegravir, dolutegravir)...
Since the introduction of the first antiretroviral agent for HIV treatment, information on antiretro...
Combination antiretroviral therapy against the hu-man immunodeficiency virus (HIV) has been re-marka...
Human immunodeficiency virus type 1 (HIV-1) is the causative agent of acquired immunodeficiency dise...
Prophylactic use of antimicrobial agents and microbicides has been proven for many infections, inclu...
Infection convened by the Department of Health and Human Services (DHHS) and the Henr
Highly active antiretroviral therapy (HAART),the use of combinations of antiretroviral drugs that ca...
The most significant advance in the medical management of HIV-1 infection has been the treatment of ...
A series of clinical endpoint studies have recently provided evidence that improved clinical outcome...
An article published by the NEJM exploring the sociodemographic differences in prophylactic therapy ...
The article presents the results of major international studies (STARTMRK, ACTG A5257, SPRING 2, the...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
ImportanceAntiretroviral therapy (ART) is the cornerstone of prevention and management of HIV infect...
ImportanceData on the use of antiretroviral drugs, including new drugs and formulations, for the tre...
This article gives a brief review of anti-retroviral agents with activity against the Human Immunode...
The article examines the efficacy and safety of HIV integrase inhibitors (raltegravir, dolutegravir)...
Since the introduction of the first antiretroviral agent for HIV treatment, information on antiretro...
Combination antiretroviral therapy against the hu-man immunodeficiency virus (HIV) has been re-marka...
Human immunodeficiency virus type 1 (HIV-1) is the causative agent of acquired immunodeficiency dise...
Prophylactic use of antimicrobial agents and microbicides has been proven for many infections, inclu...
Infection convened by the Department of Health and Human Services (DHHS) and the Henr
Highly active antiretroviral therapy (HAART),the use of combinations of antiretroviral drugs that ca...
The most significant advance in the medical management of HIV-1 infection has been the treatment of ...
A series of clinical endpoint studies have recently provided evidence that improved clinical outcome...
An article published by the NEJM exploring the sociodemographic differences in prophylactic therapy ...
The article presents the results of major international studies (STARTMRK, ACTG A5257, SPRING 2, the...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
ImportanceAntiretroviral therapy (ART) is the cornerstone of prevention and management of HIV infect...
ImportanceData on the use of antiretroviral drugs, including new drugs and formulations, for the tre...